KRSA Korsana Biosciences, Inc.
Pharmaceutical Preparations · Nasdaq · SEC CIK 1755237 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-264.6%
TTM EPS YoY169.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-42.2%
ROA-33.1%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets9.9%
Debt / equity0.00x
Current ratio10.42x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.65x
Accruals ratio-11.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.07M | $2.00M |
| R&D expense | $959,000 | $286,000 |
| SG&A expense | $6.09M | $5.34M |
| Operating income | -$4.97M | -$3.63M |
| Pretax income | -$3.53M | -$3.06M |
| Income tax | $0 | $0 |
| Net income | -$3.53M | -$3.06M |
| EPS (basic) | -1.11 | -1.21 |
| EPS (diluted) | -1.11 | -1.21 |
| Weighted avg. shares (diluted) | 3.18M | 2.52M |
| Balance sheet | ||
| Cash & equivalents | $154.13M | $10.11M |
| Receivables | $1.00M | $556,000 |
| Current assets | $154.60M | $4.22M |
| PP&E, net | $0 | $0 |
| Total assets | $154.60M | $9.57M |
| Current liabilities | $12.49M | $725,000 |
| Total liabilities | $13.03M | $725,000 |
| Shareholders' equity | -$33.97M | $66,000 |
| Shares outstanding | 1.24M | 2.55M |
| Cash flow statement | ||
| Operating cash flow | -$3.31M | -$4.33M |
| Investing cash flow | — | $0 |
| Financing cash flow | $3.32M | $0 |
| Stock-based compensation | $441,000 | $625,000 |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.